← Back to Search

Walking Program for Cancer Recovery

N/A
Waitlist Available
Led By Virginia Sun, RN, PhD
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 65 years or older
Aged 21 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 months
Awards & highlights

Study Summary

This trial will test if a walking program can help improve quality of life for older adults with cancer and their caregivers.

Who is the study for?
This trial is for older adults aged 65 and over with lung or gastrointestinal cancer, including colorectal, pancreatic, or liver cancer. They must be scheduled for surgery and have a primary caregiver willing to participate. Both patient and caregiver need to understand English and consent to the study. Those who may not follow safety requirements are excluded.Check my eligibility
What is being tested?
The trial is testing a walking program called 'Walking for Recovery from Surgery' aimed at improving quality of life after surgery for both patients with certain cancers and their caregivers. Participants will engage in this exercise intervention alongside regular surveys and quality-of-life assessments.See study design
What are the potential side effects?
Since the intervention involves a walking program rather than medication, side effects are minimal but could include general discomfort or fatigue associated with physical activity. The impact on individual well-being will be monitored through surveys.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I am 21 years old or older.
Select...
I have been diagnosed with lung, colorectal, pancreatic, or liver cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
6-minute walking time (patients)
Distress assessed using Distress thermometer (caregivers)
Distress level assessed using Distress Thermometer (patients)
+9 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive Care (Walking for Recovery from Surgery)Experimental Treatment3 Interventions
Patients and caregivers receive Walking for Recovery from Surgery prehabilitation intervention in 4 sessions 3-7 days before surgery, before discharge, and at 2 and 7 days post-discharge.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise Intervention
2016
Completed Phase 4
~1330

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,380 Total Patients Enrolled
Virginia Sun, RN, PhDPrincipal InvestigatorCity of Hope Medical Center
1 Previous Clinical Trials
355 Total Patients Enrolled

Media Library

Walking for Recovery from Surgery Clinical Trial Eligibility Overview. Trial Name: NCT03267524 — N/A
Gastrointestinal Cancer Research Study Groups: Supportive Care (Walking for Recovery from Surgery)
Gastrointestinal Cancer Clinical Trial 2023: Walking for Recovery from Surgery Highlights & Side Effects. Trial Name: NCT03267524 — N/A
Walking for Recovery from Surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT03267524 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for volunteers in this experiment?

"Data on clinicaltrials.gov suggests that this medical trial is currently seeking participants, with initial recruitment beginning 11/9/2017 and the most recent update being posted 2/17/2022."

Answered by AI

How many participants are being treated as part of this research trial?

"Affirmative. The study's information on clinicaltrials.gov confirms that the trial is still recruiting participants. It was initially made available to the public on November 9th 2017 and most recently updated February 17th 2022, aiming for 80 patients from 1 medical centre in total."

Answered by AI
~7 spots leftby Nov 2024